Toxicity of MRI and CT contrast agentsInfluence of light on aryl hydrocarbon receptor signaling and consequences in drug metabolism, physiology and diseaseDose adjustment of the non-nucleoside reverse transcriptase inhibitors during concurrent rifampicin-containing tuberculosis therapy: one size does not fit allNon-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamilyPathophysiological significance of c-jun N-terminal kinase in acetaminophen hepatotoxicityThe pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19Role of reactive metabolites in the circulation in extrahepatic toxicityDrug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systemsCytomegalovirus antivirals and development of improved animal modelsDenosumab for the treatment of osteoporosisWeb tools for predictive toxicology model buildingRegulation of drug-metabolizing enzymes by local and systemic liver injuriesTransgenic mice and metabolomics for study of hepatic xenobiotic metabolism and toxicityCurrent strategies with eptifibatide and other antiplatelet agents in percutaneous coronary intervention and acute coronary syndromesClopidogrel: an updated and comprehensive reviewRole of osteopontin in regulating hepatic inflammatory responses and toxic liver injuryEpinastine: topical ophthalmic second generation antihistamine without significant systemic side effectsThe role of aldehyde oxidase in drug metabolismClinical updates on carvedilol: a first choice beta-blocker in the treatment of cardiovascular diseasesMecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEXBis(monoacylglycerol)phosphate as a non-invasive biomarker to monitor the onset and time-course of phospholipidosis with drug-induced toxicitiesAmbroxol in the 21st century: pharmacological and clinical updatePentostatin in chronic lymphocytic leukemiaMechanism of action and toxicities of purgatives used for colonoscopy preparationThe Simcyp population-based ADME simulatorToxicological considerations when creating nanoparticle-based drugs and drug delivery systemsAlterations of chemotherapeutic pharmacokinetic profiles by drug-drug interactionsPregnane X receptor and natural products: beyond drug-drug interactionsEngineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediationPharmacokinetic drug evaluation of vorapaxar for secondary prevention after acute coronary syndrome.Allopurinol: insights from studies of dose-response relationships.Drug-induced liver injury: Is chronic liver disease a risk factor and a clinical issue?Pharmacokinetic drug evaluation of selexipag for the treatment of pulmonary arterial hypertension.Pharmacodynamic and pharmacokinetic evaluation of insulin glargine U300 for the treatment of type 1 diabetes.Pharmacokinetics and pharmacodynamics of insulin glargine 300 U/mL in the treatment of diabetes and their clinical relevance.Drug interactions between antiretrovirals and drugs used to treat benign prostatic hyperplasia/lower urinary tract symptoms.Pharmacotherapy during pediatric extracorporeal membrane oxygenation: a review.Progress and prospects in pharmacogenetics of antidepressant drugs.Hepatotoxicity of targeted therapy for cancer.Insights into the pharmacokinetic properties of antitubercular drugs.
P1433
Q22306013-1F6E1ABC-407C-44CC-AFEC-2E11E9A37100Q23919671-A16FB955-23CE-4C99-A4D1-91253989B109Q24609011-9B4C7227-EB86-4757-A7A2-10AB6FDE7A42Q24655095-5FDFFD70-7B08-40F7-BEA4-03A417D20C02Q26799194-E4ACA111-B5B9-421B-9E53-28ADD64B4BC3Q26801867-408F70A7-39D6-4B6E-80A3-D09D3D5A2E24Q26849288-18312D1C-AEFB-4737-889A-C3661AB9D178Q26851241-824608DA-C7A2-4ADD-AAD2-CA87A64B0136Q27000998-054FBD78-3E71-471D-AAFA-EA9C258CFDBAQ27009275-8484883B-F77E-4B9C-B73B-6C260D71154AQ27010340-5BF7B3DB-B5DA-4CB8-8183-86EE7FF5AA9EQ28067682-2DCDDD2B-195D-4114-B27B-6DF631B24751Q28087473-33521CD1-6D7F-4BCF-B1E3-44569C2EEB10Q28199725-65CAB4FE-4602-4071-9C3C-656416AA31BDQ28219411-135CA691-61AD-4652-9A5F-760BA788707AQ28240608-B72DC3C8-8C46-43AB-B663-8B525C56745BQ28252888-21C4BC09-0E8C-4277-893B-FD44FA8158D0Q28259834-6E271303-B2CF-439A-AEB0-F6EA35CA1724Q28270431-71B7CCBA-906F-4469-9E0F-685E514749C6Q28273812-271E01FB-87E7-42BB-897A-762DEE758292Q28278771-92F7FC9C-11C3-4AEE-A88B-562B091E3EAEQ28289778-B8E0D6DE-BF27-45A4-9FC7-CDE744652DE1Q28291531-C85183B1-EB99-44DA-A459-09DA590C912EQ28301169-9AF3CCDE-D635-4436-B481-61B18B620122Q28308225-8133AA85-4796-4B86-9FF7-0D0FB615FFA7Q28395046-037908F9-E90D-43BD-9F6B-535D610F1704Q28710150-EE118928-8976-465B-82A7-2DDCF608F4FAQ28748504-433C3363-7834-4DB3-B1C6-3A92DD483F2CQ28749176-A0538BD4-6948-430D-B079-06FEB2143C96Q30238719-E849C80F-2B8B-4486-9D8E-D3B58EE7FC9DQ30240163-856945F2-A023-4C01-8E85-29F04ADCB0D5Q30241648-C7669D8C-A6F1-45FA-BA31-9DC7B29789A3Q30244352-0CD8053B-4B7A-430E-9F88-A42BEE394018Q30244827-EEAB414A-7036-4185-AEB8-BA2C36F801FBQ30248803-CC648270-4DC8-406B-A64A-59C2C7799362Q30249162-F2574ACC-C3C8-4B52-8E31-2C1D8E96629EQ30249512-638FC40A-8307-46CC-A2AC-D79B209CC970Q30249569-59B57C76-0CBE-41E7-9220-350F13F292C0Q30250288-BC8EBB83-76F8-4170-9073-C500FCFEE8C4Q30251497-11007EC9-9350-4B36-A145-F71FA3FAFE27
P1433
description
begutachtete wissenschaftliche Zeitschrift
@de
peer-reviewed scientific journal
@en
revista científica
@es
revue scientifique
@fr
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Informa
@nl
рецензований науковий журнал
@uk
वैज्ञानिक पत्रिका
@hi
name
Expert Opinion on Drug Metabolism & Toxicology
@ast
Expert Opinion on Drug Metabolism & Toxicology
@de
Expert Opinion on Drug Metabolism & Toxicology
@en
Expert Opinion on Drug Metabolism & Toxicology
@es
Expert Opinion on Drug Metabolism & Toxicology
@fr
Expert Opinion on Drug Metabolism & Toxicology
@it
Expert Opinion on Drug Metabolism & Toxicology
@nl
type
label
Expert Opinion on Drug Metabolism & Toxicology
@ast
Expert Opinion on Drug Metabolism & Toxicology
@de
Expert Opinion on Drug Metabolism & Toxicology
@en
Expert Opinion on Drug Metabolism & Toxicology
@es
Expert Opinion on Drug Metabolism & Toxicology
@fr
Expert Opinion on Drug Metabolism & Toxicology
@it
Expert Opinion on Drug Metabolism & Toxicology
@nl
prefLabel
Expert Opinion on Drug Metabolism & Toxicology
@ast
Expert Opinion on Drug Metabolism & Toxicology
@de
Expert Opinion on Drug Metabolism & Toxicology
@en
Expert Opinion on Drug Metabolism & Toxicology
@es
Expert Opinion on Drug Metabolism & Toxicology
@fr
Expert Opinion on Drug Metabolism & Toxicology
@it
Expert Opinion on Drug Metabolism & Toxicology
@nl
P243
P3181
P4616
P1055
P1058
P1156
4700152856
P1159
P123
P1277
P1476
Expert Opinion on Drug Metabolism & Toxicology
@en
P236
P243
P3181
P407
P571
2005-01-01T00:00:00Z